Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacovigilance Follow-up Procedures

Posted on By

SOP for Pharmacovigilance Follow-up Procedures

Guidelines for Pharmacovigilance Follow-up Procedures

1) Purpose

The purpose of this SOP is to establish standardized procedures for conducting follow-up activities for pharmacovigilance cases to ensure comprehensive data collection and accurate case assessment.

2) Scope

This SOP applies to all pharmacovigilance personnel involved in follow-up activities, including safety specialists, case handlers, and managers.

3) Responsibilities

The Follow-up Team is responsible for initiating and managing follow-up activities for pharmacovigilance cases. The Pharmacovigilance (PV) Manager oversees the process to ensure compliance with regulatory requirements and internal standards.

4) Procedure

4.1 Identification of Follow-up Needs

  1. Review the initial case report to identify missing or unclear information that requires follow-up.
  2. Determine the priority of the follow-up based on the seriousness and potential impact of the adverse event.
  3. Document the identified follow-up needs and the rationale for follow-up.
See also  SOP for Pharmacovigilance Data Entry

4.2 Initiation of Follow-up

  1. Contact the reporter or healthcare professional who submitted the initial case report to request additional information.
  2. Use standardized follow-up forms or questionnaires to ensure consistency and completeness of information.
  3. Document all follow-up requests and communications in the pharmacovigilance database.

4.3 Follow-up Data Collection

  1. Collect the requested information from the reporter or healthcare professional, ensuring clarity and accuracy.
  2. Record the follow-up information in the pharmacovigilance database, updating the case file accordingly.
  3. Verify the completeness and accuracy of the collected
follow-up data.

4.4 Follow-up Data Assessment

  1. Review the follow-up information to assess its impact on the overall case evaluation.
  2. Update the seriousness, expectedness, and causality assessment of the case based on the new information.
  3. Document the follow-up assessment and any changes to the case evaluation in the pharmacovigilance database.

4.5 Continuous Monitoring and Further Follow-up

  1. Monitor the case for any additional information or changes in the patient’s condition that may require further follow-up.
  2. Initiate additional follow-up requests as needed to obtain comprehensive and current case information.
  3. Document all further follow-up activities and updates in the pharmacovigilance database.

4.6 Quality Control

  1. Conduct regular quality control checks on follow-up activities to ensure accuracy and completeness.
  2. Address any issues or errors identified during quality control checks promptly.
  3. Document all quality control activities and any corrective actions taken.

4.7 Documentation and Record Keeping

  1. Maintain detailed records of all follow-up activities, including follow-up requests, responses, and assessments.
  2. Ensure all documentation is securely stored and easily accessible for audits and inspections.
  3. Keep a log of all data corrections and updates made during the follow-up process.

4.8 Communication

  1. Communicate follow-up procedures and updates to all relevant staff members.
  2. Provide training on follow-up tools and techniques to ensure consistency and quality.
  3. Report any issues or challenges encountered during follow-up activities to the PV Manager.

5) Abbreviations, if any

PV – Pharmacovigilance

6) Documents, if any

Initial case reports, follow-up forms, follow-up communications, quality control reports.

7) Reference, if any

ICH E2E Pharmacovigilance Planning, EU Good Pharmacovigilance Practices (GVP) Module VI.

8) SOP Version

Version 1.0

See also  SOP for Pharmacovigilance Incident Management
Pharmacovigilance Tags:Pharmacovigilance adverse event reporting SOP, Pharmacovigilance audit preparation SOP, Pharmacovigilance case processing SOP, Pharmacovigilance compliance monitoring SOP, Pharmacovigilance compliance SOP, Pharmacovigilance data collection SOP, Pharmacovigilance data privacy SOP, Pharmacovigilance database management SOP, Pharmacovigilance documentation management SOP, Pharmacovigilance guidelines, Pharmacovigilance literature review SOP, Pharmacovigilance medical review SOP, Pharmacovigilance periodic reporting SOP, Pharmacovigilance procedure document, Pharmacovigilance quality management SOP, Pharmacovigilance regulatory reporting SOP, Pharmacovigilance risk assessment SOP, Pharmacovigilance risk management plan SOP, Pharmacovigilance risk minimization SOP, Pharmacovigilance safety reporting SOP, Pharmacovigilance signal detection SOP, Pharmacovigilance signal management SOP, Pharmacovigilance SOP template, Pharmacovigilance system master file SOP, Pharmacovigilance training program SOP

Post navigation

Previous Post: SOP for Maintenance of Cartoning Machines
Next Post: SOP for Analytical Method Development Physical Testing Method Development

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version